Chris Rao discusses the impact of COVID-19 on clinical trials
Clinical trials have been heavily impacted by the COVID-19 crisis, affecting companies in all stages of development. Alira Health’s Christopher Rao, Vice President, Clinical Development, talks about the current disruption, the recently released FDA guidelines, and his best advice for companies who are in the midst of (or just starting) clinical trial work during this challenging time.
For more information, please contact Chris at firstname.lastname@example.org
Additional COVID-19 resources:
Download our latest report: COVID-19: Monitoring Impacts and Anticipating Trends to Limit Downturn and Optimize Rebound. Click here to download.
Watch a replay of our webinar: The COVID-19 Supply Shortage: Causes, Impact, and Solutions. Click here to watch.
Take our COVID-19 Impact Survey. Click here to take the survey.